URC-CIC Paris Descartes Necker Cochin

• NCT07564245

  Collaborator, Phase 2, Not yet recruiting, 21 people, 4 May 2026

• NCT06818266

  Collaborator, Phase 3, Recruiting, 130 people, 10 Feb 2025

• NCT06464146

  Collaborator, Phase 3, Recruiting, 300 people, 18 Jun 2024

• Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction

  Collaborator, Phase 2, Terminated, 8 people, 18 Jan 2024

• NCT05762640

  Collaborator, Phase 2, Recruiting, 20 people, 9 Mar 2023

• Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)

  Collaborator, Phase 2, Completed, 35 people, 18 Jan 2023

• NCT05651607

  Collaborator, Phase 2, Completed, 10 people, 15 Dec 2022

• NCT05524311

  Collaborator, Phase 2, Completed, 16 people, 1 Sept 2022

• Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

  Collaborator, Phase 3, Completed, 102 people, 1 Sept 2021

• NCT04871191

  Collaborator, Phase 3, Recruiting, 42 people, 4 May 2021

• NCT04838717

  Collaborator, Phase 3, Completed, 200 people, 9 Apr 2021

• NCT04316611

  Collaborator, Phase 2, Withdrawn, 0 people, 20 Mar 2020

• NCT03887169

  Collaborator, Phase 1/2, Completed, 3 people, 22 Mar 2019

• NCT03776656

  Collaborator, Phase 2, Completed, 8 people, 17 Dec 2018

• NCT03401060

  Collaborator, Phase 3, Completed, 24 people, 17 Jan 2018

• NCT02905799

  Collaborator, Phase 3, Completed, 142 people, 19 Sept 2016

• NCT02840175

  Collaborator, Phase 3, Completed, 62 people, 21 Jul 2016

• NCT02807103

  Collaborator, Phase 3, Completed, 107 people, 21 Jun 2016

• NCT02678533

  Collaborator, Phase 1/2, Completed, 4 people, 9 Feb 2016

• NCT02477007

  Collaborator, Phase 3, Completed, 304 people, 22 Jun 2015

Sources: clinicaltrials.gov